Article info

PDF

Research
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

Authors

  1. Correspondence to Dr Paola Di Maggio, UK Medical Affairs, Norgine, Moorhall Road, Harefield, Uxbridge, London UB9 6NS, UK; pdimaggio{at}norgine.com
View Full Text

Citation

Hudson M, Radwan A, Di Maggio P, et al
The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

Publication history

  • Received December 9, 2016
  • Revised March 6, 2017
  • Accepted March 17, 2017
  • First published April 7, 2017.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.